Effect of upadacitinib on extraintestinal manifestations in patients with moderately to severely active Crohn's disease

被引：0

作者：

Wright, Emily K. ^{[1
,2
]}

Colombel, Jean-Frederic ^{[3
]}

Hudesman, David ^{[4
]}

Cao, Qian ^{[7
]}

Ghosh, Subrata ^{[8
]}

Reinisch, Walter ^{[9
]}

Lacerda, Ana ^{[5
]}

Dubcenco, Elena ^{[5
]}

Doshi, Chirag ^{[5
]}

Anyanwu, Samuel ^{[5
]}

Feng, Tian ^{[5
]}

Rubin, David ^{[6
]}

机构：

[1] St Vincents Hosp, Melbourne, Vic, Australia

[2] Univ Melbourne, Melbourne, Vic, Australia

[3] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY USA

[4] NYU Langone Hlth, Div Gastroenterol, Ctr Inflammatory Bowel Dis, New York, NY USA

[5] AbbVie Inc, N Chicago, IL USA

[6] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[7] Zhejiang Univ, Sir Run Shaw Hosp, Ctr Inflammatory Bowel Dis, Coll Med,Dept Gastroenterol, Hangzhou, Peoples R China

[8] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland

[9] Med Univ Vienna, Clin Dept Gastroenterol & Hepatol, Vienna, Austria

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：159 / 160

页数：2

共 50 条

[31] Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn's disease: results from the U-ENDURE long-term extension [J].

Mitrev, Nikola ;

D'Haens, Geert ;

Louis, Edouard ;

Loftus, Edward, Jr. ;

Regueiro, Miguel ;

Jairath, Vipul ;

Magro, Fernando ;

Nakase, Hiroshi ;

Dubcenco, Elena ;

Lacerda, Ana ;

Feng, Tian ;

Duncan, Benjamin ;

Wang, Tao ;

Ford, Sharanya ;

Anyanwu, Samuel ;

Blumenstein, Irina .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 :161-162

[32] Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn's Disease: results from the U-ENDURE long-term extension [J].

D'Haens, G. ;

Louise, E. ;

Loftus, E. V., Jr. ;

Regueiro, M. ;

Jairath, V. ;

Magro, F. ;

Nakase, H. ;

Dubcenco, E. ;

Lacerda, A. P. ;

Feng, T. ;

Duncan, B. ;

Wang, T. ;

Ford, S. ;

Anyanwu, S. I. ;

Juilleratm, P. ;

Blumenstein, I. .

SWISS MEDICAL WEEKLY, 2024, 154 :2S-2S

[33] Clinical Benefit of Adalimumab Dose Adjustment for Patients With Moderately to Severely Active Crohn's Disease in EXTEND [J].

Colombel, Jean-Frederic ;

Rutgeerts, Paul ;

Sandborn, William ;

Wolf, Douglas ;

Reinisch, Walter ;

Van Assche, Gert ;

Eichner, Samantha ;

Zhou, Qian ;

Petersson, Joel ;

Robinson, Anne ;

Thakkar, Roopal .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 :S474-S474

[34] Meta-analysis of placebo remission rate for patients with moderately to severely active Crohn's disease [J].

Loftus, Edward, Jr. ;

Wu, Eric ;

Johnson, Scott ;

Chao, Jingdong ;

Mulani, Parvez .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 :S380-S381

[35] Use of Certolizumab Pegol in the Management of Acute Extraintestinal Manifestations of Active Crohn's Disease [J].

Randall, Charles ;

Ford, Janet .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 :S354-S354

[36] Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately to Severely Active Crohn's Disease [J].

Sands, Bruce E. ;

Gasink, Christopher ;

Jacobstein, Douglas ;

Ott, Elyssa ;

Lang, Yinghua ;

Ramachandran, Paraneedharan ;

Ghosh, Subrata .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 :S329-S330

[37] Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease [J].

Harris, Sarah ;

Feagan, Brian G. ;

Hanauer, Stephen ;

Vermeire, Severine ;

Ghosh, Subrata ;

Yan, Jim ;

Wu, Chun ;

Hu, Yanhua ;

Maddux, Rachel ;

Wolf, Douglas C. ;

D'Haens, Geert .

DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (06) :2044-2054

[38] Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease in the Care Trial [J].

Louis, Edouard ;

Lofberg, Robert ;

Reinisch, Walter ;

Kron, Martina ;

Camez, Anne ;

Robinson, Anne ;

Pollack, Paul F. .

GASTROENTEROLOGY, 2009, 136 (05) :A196-A196

[39] Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease [J].

Louis, Edouard ;

Lee, Wan-Ju ;

Litcher-Kelly, Leighann ;

Ollis, Sarah ;

Pranschke, Emma ;

Fitzgerald, Kristina ;

Lacerda, Ana Paula ;

Neimark, Ezequiel ;

Gonzalez, Yuri Sanchez ;

Panes, Julian .

ADVANCES IN THERAPY, 2024, 41 (09) :3678-3705

[40] Dual Advanced Therapies and Novel Pharmacotherapies for Moderately to Severely Active Crohn's Disease [J].

Tse, Chung Sang ;

Dulai, Parambir S. .

GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) :283-298

← 1 2 3 4 5 →